# Epigenetics Based Diagnosis of Diabetes in Saliva and Blood Samples

> **NCT04011228** · — · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 224 (estimated)

## Conditions studied

- Prediabetic State
- Diabetes Mellitus, Type 2
- Ectopic Lipids
- Epigenetics Based Modifications

## Interventions

- **DIAGNOSTIC_TEST:** Blood sampling
- **DIAGNOSTIC_TEST:** Saliva and blood samples
- **DIAGNOSTIC_TEST:** Magnet Resonance Spectroscopy

## Key facts

- **NCT ID:** NCT04011228
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02-29
- **Primary completion:** 2019-12-11
- **Final completion:** 2020-01-01
- **Target enrollment:** 224 (ESTIMATED)
- **Last updated:** 2019-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04011228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04011228, "Epigenetics Based Diagnosis of Diabetes in Saliva and Blood Samples". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04011228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*